MedTrace Logo

Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis

NCT00769184 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2015-08-19

Study results available
· View outcomes & findings →

Summary

This is a 12 week bilateral study, consisting of 6 weeks of treatment and 6 weeks of follow-up. The purpose of the study is to compare the safety and effectiveness of combining and then following a high potency topical corticosteroid treatment with LCD treatment for moderate-to-severe localized plaque psoriasis.

Conditions

Interventions

DRUG

Corticosteroid

One side of body: clobetasol: 2 applications / day along with LCD application 2 applications/day

OTHER

Placebo

One side of body: Placebo Solution: 2 applications / day along with clobetasol 2 applications/day

DRUG

LCD

One side of body: LCD Solution: 2 applications / day along with clobetasol 2 applications/day

Sponsors & Collaborators

  • NeoStrata Company, Inc.

    lead INDUSTRY

Principal Investigators

  • Jerry Bagel, MD · Psoriasis Treatment Center of Central New Jersey

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00769184 on ClinicalTrials.gov